Skip to content

Enhanced Recovery After Surgery in Patients Undergoing Colorectal Cancer Surgery

Impact of an Enhanced Recovery After Surgery (ERAS) Protocol on Postoperative Recovery in Patients Undergoing Surgery for Colorectal Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07889934
Enrollment
91
Registered
2026-10-22
Start date
2024-09-17
Completion date
2025-07-30
Last updated
2026-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colorecatal Cancer Surgery

Keywords

Enhanced Recovery After Surgery, ERAS, Colorectal Cancer, Colorectal Surgery, Perioperative Care, Postoperative Recovery, Length of Stay, Postoperative Complications, Postoperative Pain, Early Mobilization, Bowel Function, Nursing Care

Brief summary

This study compared an Enhanced Recovery After Surgery (ERAS) care program with conventional perioperative care in adults undergoing surgery for colorectal cancer. Participants were randomly assigned to receive either ERAS care or usual care. The ERAS program included coordinated measures before, during, and after surgery aimed at supporting faster and safer recovery. The study evaluated whether ERAS could reduce the length of hospital stay and improve postoperative recovery. Other outcomes included early mobilization, return of bowel function and oral feeding, postoperative pain, complications and adverse events, removal of urinary catheters and drains, discontinuation of intravenous therapy, and selected laboratory measures. The study was conducted at the General Anticancer Oncology Hospital of Athens "Saint Savvas" in Greece.

Detailed description

Enhanced Recovery After Surgery (ERAS) programs are multimodal, evidence-based perioperative care pathways designed to reduce the physiological stress of surgery and promote earlier functional recovery. In colorectal cancer surgery, recovery may be influenced by several factors, including postoperative pain, delayed mobilization, gastrointestinal dysfunction, prolonged intravenous therapy, and the continued use of catheters and drains. This randomized controlled study was conducted to evaluate the implementation of an ERAS pathway in adult patients undergoing surgical resection for colorectal cancer and to compare postoperative recovery with that achieved through conventional perioperative care. The ERAS pathway incorporated coordinated interventions across the perioperative period, including preoperative preparation and education, perioperative analgesic management, postoperative mobilization, nutritional recovery, and planned discontinuation of supportive devices and therapies. The study focused on clinically relevant indicators of postoperative recovery. Particular attention was given to the duration of postoperative hospitalization, return of gastrointestinal function, mobilization, postoperative pain, complications and adverse events, and the timing of withdrawal of supportive interventions. Laboratory parameters were also assessed as complementary indicators of perioperative recovery. The study was conducted in a real-world oncology hospital setting and was intended to assess whether a structured ERAS pathway could improve postoperative recovery compared with the conventional perioperative care routinely provided to patients undergoing colorectal cancer surgery.

Interventions

A multimodal perioperative care pathway applied before, during, and after colorectal cancer surgery, designed to reduce surgical stress and accelerate functional recovery.

Routine perioperative care provided at the study center to patients undergoing colorectal cancer surgery.

Sponsors

University of West Attica
Lead SponsorOTHER
Saint Savvas Anticancer Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Masking was not feasible because the ERAS pathway involved identifiable perioperative care practices implemented by the clinical team.

Intervention model description

Participants were assigned to one of two parallel groups: an Enhanced Recovery After Surgery (ERAS) perioperative care pathway or conventional perioperative care. Outcomes were assessed during the postoperative period through hospital discharge.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Diagnosis of colorectal cancer. * Scheduled to undergo surgical resection of the colorectal tumor. * Ability to understand and communicate in Greek. * Sufficient cognitive capacity to understand the study information, provide informed consent, and participate in the study procedures.

Exclusion criteria

* Current treatment for chronic pain. * Use of psychopharmacological medication as defined in the study protocol. * Acute or chronic renal disease. * Acute or chronic hepatic disease.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Length of Hospital StayFrom the date of surgery to hospital discharge, up to approximately 14 daysNumber of calendar days from the date of surgery to the date of hospital discharge, obtained from the hospital medical record. A shorter postoperative hospital stay indicates earlier discharge after colorectal cancer surgery.

Secondary

MeasureTime frameDescription
Time to First Postoperative MobilizationFrom surgery until first mobilization, assessed during the first postoperative day and thereafter if neededTime from completion of surgery to the patient's first mobilization out of bed. Recovery time was recorded using predefined postoperative time categories: 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Time to Full Postoperative MobilizationFrom surgery until full mobilizationTime from surgery until the patient achieved full postoperative mobilization. Time was recorded in predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Time to Return of Gastrointestinal MotilityFrom surgery until return of gastrointestinal motilityTime from surgery to documented return of gastrointestinal motility. Recovery time was recorded using predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Time to Postoperative Oral FeedingFrom surgery until resumption of oral feedingTime from surgery to resumption of postoperative oral feeding, recorded using predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Postoperative Pain Intensity0-2, 2-6, 6-12, and 12-24 hours after surgery; postoperative days 1, 2, and 3; and at hospital dischargePostoperative pain intensity assessed using a four-category verbal rating scale: 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = very severe pain. Pain was assessed repeatedly during the postoperative period.
Occurrence of Postoperative Complications and Adverse EventsFrom surgery until hospital dischargeOccurrence of one or more predefined postoperative complications or adverse events, including nausea, vomiting, constipation, drowsiness, sedation, fever, local inflammation, bleeding, urinary tract infection, urinary retention, ileus, and reoperation. Events were recorded individually and as a composite binary outcome indicating the occurrence of any complication or adverse event.
Time to Urinary Catheter RemovalFrom surgery until urinary catheter removalTime from surgery to removal of the urinary catheter, recorded using predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Time to Surgical Drain RemovalFrom surgery until drain removalTime from surgery to removal of postoperative surgical drains, recorded using predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.
Time to Discontinuation of Intravenous TherapyFrom surgery until discontinuation of intravenous therapyTime from surgery to discontinuation of postoperative intravenous therapy, recorded using predefined categories of 0-6, 6-12, 12-18, 18-24, and more than 24 hours.

Countries

Greece

Contacts

STUDY_CHAIRMartha Kelesi, Prof

Nursing Department, University of West Attica

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 23, 2026